©The Author(s) 2022.
World J Clin Cases. Aug 26, 2022; 10(24): 8599-8614
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8599
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8599
Table 1 Study schedule of enrollment, intervention, and assessment
| Enrollment | Pre-allocation | Allocation | Post-intervention | |
| Duration | 12 wk | 1 wk | 12 wk | |
| Eligibility | x | |||
| Informed consent | x | |||
| Clinical interview | x | x | ||
| Demographic question | x | |||
| Intervention | ||||
| Unified protocol | - | |||
| Treatment as usual | - | |||
| Primary outcome | ||||
| OASIS | x | x | ||
| ODSIS | x | x | ||
| Secondary outcomes | ||||
| DERS | x | x | ||
| ESQ | x | x | ||
| PANAS | x | x | ||
- Citation: Yan K, Yusufi MH, Nazari N. Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial. World J Clin Cases 2022; 10(24): 8599-8614
- URL: https://www.wjgnet.com/2307-8960/full/v10/i24/8599.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i24.8599